TNF-α recombinant protein supports inflammatory immune regulation and biologics evaluation

Author: Senior Product Manager of UA Views：10

TNF-α is a key inflammatory cytokine produced by activated macrophages, T cells, neutrophils, and other cells. It exists in two active forms, transmembrane and secreted, and can participate in immune homeostasis regulation and disease progression by inducing inflammation, apoptosis, angiogenesis, and bone destruction.

Recent Advances
Product Information

Recent Advances

TNF-α Recombinant Protein Supports Inflammatory Immune Regulation and Biologics Evaluation

Brief Introduction: TNF-α is a key inflammatory cytokine produced by activated macrophages, T cells, neutrophils, and other cells. It exists in two active forms, transmembrane and secreted, and participates in immune homeostasis regulation and disease progression by inducing inflammation, apoptosis, angiogenesis, and bone destruction. TNF-α recombinant protein can be used for receptor binding, signaling pathway studies, antibody screening, biosimilar evaluation, and inflammatory model research, making it an important tool in immunology, tumor microenvironment, and autoimmune disease research.

I. TNF-α Is a Key Cytokine Regulating Inflammatory Responses and Tissue Homeostasis.

TNF-α is a member of the tumor necrosis factor superfamily and was initially named for its ability to induce hemorrhagic necrosis of tumors in animal models. Subsequent studies found that TNF-α is not only an important mediator of inflammatory responses but also a key signaling molecule coordinating cell survival, apoptosis, immune activation, and tissue repair. Under physiological conditions, TNF-α participates in host defense, infection control, and maintenance of tissue homeostasis; under pathological conditions, its sustained or excessive expression may promote chronic inflammation, immune imbalance, angiogenesis, bone destruction, and tumor microenvironment remodeling.

II. TNF-α Is Produced by Various Immune Cells and Tumor Microenvironment Cells.

TNF-α is mainly produced by activated macrophages, but can also be secreted by CD4+ T cells, neutrophils, mast cells, dendritic cells, endothelial cells, and some tumor-associated cells. In the tumor-associated microenvironment, both malignant cells and infiltrating immune cells can produce TNF-α, enabling it to participate in anti-tumor immunity while also potentially promoting tumor progression through a chronic inflammatory environment. This dual role depends on cell type, receptor signaling intensity, microenvironment composition, and disease stage.

III. TNF-α Exists in Two Biologically Active Forms: Transmembrane and Secreted.

TNF-α is initially expressed on the cell surface as transmembrane tmTNF-α, which is subsequently cleaved by the matrix metalloproteinase TACE/ADAM17 to remove approximately 76 amino acid residues from the amino terminus, forming soluble secreted sTNF-α. Both tmTNF-α and sTNF-α can bind to TNFR1 and TNFR2, but they differ in signaling intensity, cell type specificity, and biological effects. tmTNF-α is more prone to mediating cell-cell contact-dependent signaling, while sTNF-α plays an important role in humoral circulation and distal inflammatory amplification.

IV. TNF-α Regulates Cell Survival and Apoptosis Through Receptor Signaling Networks.

TNF-α mainly binds to TNFR1 and TNFR2. TNFR1 is widely expressed and can activate NF-κB, MAPK, JNK, and caspase-dependent apoptotic pathways; TNFR2 is mainly expressed in immune cells and endothelial cells and is more involved in immune regulation, cell proliferation, and tissue repair. TNF-α signal output is co-regulated by receptor abundance, ligand form, ubiquitination modifications, and downstream adaptor proteins, so it may manifest as pro-inflammatory, pro-survival, or pro-apoptotic outcomes in different cells.

V. TNF-α Drives Inflammatory Amplification and Tissue Damage in Autoimmune Diseases.

In diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, TNF-α is considered one of the key pathogenic factors. Its mechanisms of action include: inducing endothelial cells to express adhesion molecules and VEGF, promoting leukocyte adhesion, extravasation, and local inflammation; stimulating hepatocytes to produce C-reactive protein; activating osteoclasts, synoviocytes, and chondrocytes, promoting the production of metalloproteinases, collagenases, matrix-degrading enzymes, and prostaglandin E2, leading to cartilage destruction and bone erosion; and inducing synoviocytes, macrophages, fibroblasts, and chondrocytes to produce IL-1, IL-8, and other inflammatory factors, further amplifying tissue damage.

VI. TNF-α Inhibitors Are an Important Therapeutic Strategy for Various Autoimmune Diseases.

Based on the central role of TNF-α in chronic inflammation, TNF-α inhibitors have become important therapeutic drugs for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other diseases. These inhibitors mainly include monoclonal antibodies, soluble receptor fusion proteins, and nanobodies, which reduce inflammatory responses, alleviate joint destruction, and improve clinical symptoms by neutralizing sTNF-α or blocking TNF-α binding to its receptors. Different inhibitors may differ in receptor selectivity, mechanism of action, and clinical indications, and need to be evaluated in the context of specific drugs.

VII. TNF-α Recombinant Protein Is an Important Tool for Receptor Binding and Signaling Pathway Research.

TNF-α recombinant protein can be used for TNFR1/TNFR2 binding experiments, receptor affinity determination, NF-κB/MAPK/apoptosis pathway activation studies, cytokine synergy analysis, endocytosis and signal transduction mechanism evaluation, and establishment of inflammation-related cell models. By selecting recombinant proteins with stable activity and batch consistency, the reproducibility of receptor interaction studies and functional validation can be improved, providing a reliable foundation for downstream antibody screening and drug evaluation.

Conclusion

To address the research needs around the TNF-α target and recombinant protein applications, UniAI provides TNF-α Protein, Human. This product is suitable for TNF-α receptor binding analysis, inflammatory signaling pathway research, antibody screening and characterization, neutralizing activity evaluation, biosimilar comparability studies, cytokine network analysis, and immunological functional experiments. By providing stable and reliable recombinant protein tools, UniAI can provide technical support for TNF-α-related basic and translational research.

TNF-α recombinant protein is becoming an important reagent connecting inflammatory immune mechanisms, autoimmune disease research, and biologics development. As the TNF-α signaling network, receptor selectivity, and microenvironment regulatory mechanisms are further elucidated, high-quality TNF-α recombinant protein will play an even more important role in target validation, antibody evaluation, biosimilar research, and inflammatory model construction.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next